Alembic Pharmaceuticals receives USFDA Final Approval for Diclofenac Sodium Topical Solution USP, 2% w/w

Alembic Pharmaceuticals Limited has received final approval from the US Food & Drug Administration for its Abbreviated New Drug Application, Diclofenac Sodium Topical Solution USP, 2% w/w.

Related Keywords

Ireland , ,Alembic Pharmaceuticals Limited ,Alembic Pharmaceuticals ,Aleor Dermaceuticals Limited ,Us Food Drug Administration ,Diclofenac Sodium Topical Solution ,Pharmaceuticals Limited ,Drug Administration ,Abbreviated New Drug Application ,Pennsaid Topical Solution ,Horizon Therapeutics Ireland ,Alembicpharmaceuticals ,Ine901l01018 ,Usfda ,Panda ,Finalapproval ,Diclofenacsodium ,